Teva Innovative Medicine & Biosimilar Pipeline
By development stage – as of November 1, 2023
Under Regulatory Review
Ulcerative Colitis, Crohn’s Disease
Download a PDF version of Teva Innovative Medicine and Biosimilar PipelineDownload PDF
Teva innovative medicine & biosimilar pipeline by development stage, excluding country / regional launches of products submitted or under review in new markets.
Pipeline is current as of November 1, 2023.